Femara May Beat Tamoxifen at Preventing Breast Cancer's Return (HealthDay)

Admin

Administrator
Staff member
HealthDay - FRIDAY, Oct. 21 (HealthDay News) -- The breast cancer drug letrozole, marketed as Femara, may be more effective than tamoxifen at preventing the return of breast cancer and improving survival among older women with hormone-sensitive breast cancers, a new study reports.

More...
 
Top